Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
2000 Turkeys
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
2000 Turkeys
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Oragenics Inc. Common Stock
(NY:
OGEN
)
0.2010
-0.1491 (-42.59%)
Official Closing Price
Updated: 8:00 PM EST, Nov 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oragenics Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
After-Hours Stock Movers: Top Gainers and Losers Following Today's US Close
↗
November 13, 2026
Via
Chartmill
Today's US Session Top Gainers and Losers: ONFO, AKAN Lead Advances; OPTT, NPCE Fall
↗
November 13, 2026
Via
Chartmill
Unusual Volume Movers: LICN, OGEN, RAIN and More on Nov. 13, 2026
↗
November 13, 2026
Via
Chartmill
Top US Market Movers: Gainers and Losers in Today's Session
↗
November 13, 2026
Via
Chartmill
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Receives NYSE American Compliance Extension Through February 2028
November 13, 2026
Via
Investor Brand Network
Gap Movers for Nov. 13, 2026: Gap-Up and Gap-Down Stocks
↗
November 13, 2026
Via
Chartmill
Premarket Session Market Movers: Small-Cap Gainers and Losers
↗
November 13, 2026
Via
Chartmill
Postmarket Movers: After-Hours Gainers and Losers for Nov. 12, 2026
↗
November 12, 2026
Via
Chartmill
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) to Present ONP-002 Concussion Program at IPAC-RS 2026 Nasal Innovation Forum
September 16, 2026
Via
Investor Brand Network
NetworkNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Advances Phase IIa Concussion Trial, Provides FDA and Listing Updates
August 31, 2026
Via
Investor Brand Network
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Activates All Australian Phase IIa Trial Sites for ONP-002
July 07, 2026
Via
Investor Brand Network
Sidoti Events, LLC's May Micro-Cap Virtual Conference
May 20, 2026
Via
ACCESS Newswire
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) to Present at Sidoti Micro-Cap Virtual Investor Conference
May 19, 2026
Via
Investor Brand Network
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Highlights Phase IIa Progress and Strategic CNS Expansion Plans
May 18, 2026
Via
Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Signs LOI to License CardioDialysis Technology From Sigyn Therapeutics
May 07, 2026
Via
Investor Brand Network
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Advances Phase IIa Trial Enrollment For Concussion Treatment Candidate
May 05, 2026
Via
Investor Brand Network
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Reports Early Dosing Progress in Phase IIa Trial of Intranasal Concussion Therapy
April 20, 2026
Via
Investor Brand Network
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Doses First Patient in Phase IIa Trial of Concussion Treatment
April 13, 2026
Via
Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Reports Going Concern Audit Opinion Disclosure
March 26, 2026
Via
Investor Brand Network
TinyGemsBreaks – Oragenics Inc. (NYSE American: OGEN) Files 2025 Form 10-K And Provides Operational Update
March 17, 2026
Via
Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Initiates First Clinical Site for Phase IIa Trial of ONP-002 in Australia
March 12, 2026
Via
Investor Brand Network
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Explores CNS Asset Acquisitions To Expand Brain Health Pipeline
March 11, 2026
Via
Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Receives Australian Ethics Approval to Launch Phase IIa Concussion Trial
March 10, 2026
Via
Investor Brand Network
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Previews 2026 Milestones for Intranasal Concussion Therapeutic ONP-002
February 09, 2026
Via
Investor Brand Network
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Engages DUCK FLATS Pharma for IND Readiness and Regulatory Execution
February 03, 2026
Via
Investor Brand Network
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Participates in SCOPE Summit 2026 Ahead of Phase 2a Concussion Trial
February 02, 2026
Via
Investor Brand Network
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) to Present at Sequire Investor Summit 2026
January 14, 2026
Via
Investor Brand Network
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Regains NYSE Compliance, Advances Toward First Clinical Trial and Expands AI-Driven Neurology Pipeline
November 12, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Oragenics Q3 2025 Shareholder Update
November 12, 2025
From
Oragenics, Inc.
Via
Business Wire
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Regains NYSE Compliance, Strengthens Balance Sheet for Clinical Advancement
October 21, 2025
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today